2-(4-Chloro-3-nitrobenzoyl)benzoic acid → HCID 10117751, Verbindung
Reaktionsgleichung
[NH:1]1[CH2:6][CH2:5][CH:4]([N:7]2[C:16]3[C:11](=[CH:12][CH:13]=[CH:14][CH:15]=3)[CH2:10][CH2:9][C:8]2=[O:17])[CH2:3][CH2:2]1.Cl[C:19]1[CH:35]=[CH:34][C:22]([C:23]([C:25]2[CH:33]=[CH:32][CH:31]=[CH:30][C:26]=2[C:27]([OH:29])=[O:28])=[O:24])=[CH:21][C:20]=1[N+:36]([O-:38])=[O:37]>>[N+:36]([C:20]1[CH:21]=[C:22]([C:23]([C:25]2[CH:33]=[CH:32][CH:31]=[CH:30][C:26]=2[C:27]([OH:29])=[O:28])=[O:24])[CH:34]=[CH:35][C:19]=1[N:1]1[CH2:6][CH2:5][CH:4]([N:7]2[C:16]3[C:11](=[CH:12][CH:13]=[CH:14][CH:15]=3)[CH2:10][CH2:9][C:8]2=[O:17])[CH2:3][CH2:2]1)([O-:38])=[O:37]Komponenten
3
Versuchsvorschrift
The product was prepared from 1-piperidin-4-yl-3,4-dihydroquinolin-2(1H)-one (Chem. Pharm. Bull. (1996), 44(4), 725-33) (0.45 g) and 2-(4-chloro-3-nitrobenzoyl)benzoic acid (0.6 g) using the method of example 1. Used crude.
Quellen und Nachweise
- ORD-Eintrag
- ord-10fefb948d7b496eb932024b4d83431b
- Quelldatensatz
- uspto-grants-2004_11